2005-2020年中国国家和地方层面结直肠癌导致的预期寿命损失:来自中国国家死亡率监测系统的基于人群的回顾性研究

IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES The Lancet Regional Health: Western Pacific Pub Date : 2025-02-01 Epub Date: 2025-02-17 DOI:10.1016/j.lanwpc.2024.101338
Fanshu Yan, Zhe Liu, Peng Yin
{"title":"2005-2020年中国国家和地方层面结直肠癌导致的预期寿命损失:来自中国国家死亡率监测系统的基于人群的回顾性研究","authors":"Fanshu Yan,&nbsp;Zhe Liu,&nbsp;Peng Yin","doi":"10.1016/j.lanwpc.2024.101338","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Colorectal cancer was the fourth leading cause of cancer death in China in 2020, and mortality due to colorectal cancer increased in economically developed regions between 2005 and 2020. This study aimed to explore the temporal trends in loss of life expectancy due to colorectal cancer in China and all mainland provinces from 2005 to 2020.</div></div><div><h3>Methods</h3><div>The mortality data were obtained from the China National Mortality Surveillance System (NMSS), which covers a population of more than 300 million people in 31 provincial-level administrations with provincial-level representativeness. Under-reporting rate was used to adjust for death rates from all cause and colorectal cancer. The demographic data were obtained from the National Bureau of Statistic. We used the abbreviated life table method to calculate life expectancy. Loss of life expectancy due to colorectal cancer was calculated as the life expectancy after excluding colorectal cancer deaths in the whole population by gender and provinces. Underlying cause of death coded as colorectal cancer based on the International Classification of Diseases, 10th edition (ICD-10) was used (C18.0-C18.9). The study was approved by the Ethics Committee of The National Center for Chronic and Noncommunicable Disease Control and Prevention.</div></div><div><h3>Findings</h3><div>The loss of life expectancy due to colorectal cancer in China in 2020 was 0.15 years, slightly higher in men (0.154 years) than in women (0.147 years). Loss of life expectancy due to colorectal cancer is on an increasing trend between 2005 and 2020, for both genders, with a higher increase for men (0.03) than for women (0.02). The provinces with the highest loss of life expectancy due to colorectal cancer in 2020 were Beijing (0.30), Zhejiang (0.26), and Shanghai (0.26), and the lowest were Tibet (0.04), Hebei (0.09), and Henan (0.10). Among all 31 mainland provinces, 3 provinces (Hebei, Henan and Jiangxi) showed a decreasing trend for loss of life expectancy due to colorectal cancer. For the remaining provinces, Tianjin (96.97%), Fujian 80.28%), and Beijing (70.28%) had the highest increase in loss of life expectancy due to colorectal cancer during the study period.</div></div><div><h3>Interpretation</h3><div>The loss of life expectancy due to colorectal cancer is increasing during 2005-2020, indicating it remains a major public health problem in China, particularly in economically developed provinces. The strengths of this study are the use of loss of life expectancy as the indicator to measure the burden caused by colorectal cancer and its temporal trend based on nationwide data. The limitation of this study is that we were unable to analyze the associated factors for the variations between different provinces.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"55 ","pages":"Article 101338"},"PeriodicalIF":8.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Loss of life expectancy due to colorectal cancer at national and subnational level in China, 2005-2020: a retrospective population-based study from China national mortality surveillance system\",\"authors\":\"Fanshu Yan,&nbsp;Zhe Liu,&nbsp;Peng Yin\",\"doi\":\"10.1016/j.lanwpc.2024.101338\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Colorectal cancer was the fourth leading cause of cancer death in China in 2020, and mortality due to colorectal cancer increased in economically developed regions between 2005 and 2020. This study aimed to explore the temporal trends in loss of life expectancy due to colorectal cancer in China and all mainland provinces from 2005 to 2020.</div></div><div><h3>Methods</h3><div>The mortality data were obtained from the China National Mortality Surveillance System (NMSS), which covers a population of more than 300 million people in 31 provincial-level administrations with provincial-level representativeness. Under-reporting rate was used to adjust for death rates from all cause and colorectal cancer. The demographic data were obtained from the National Bureau of Statistic. We used the abbreviated life table method to calculate life expectancy. Loss of life expectancy due to colorectal cancer was calculated as the life expectancy after excluding colorectal cancer deaths in the whole population by gender and provinces. Underlying cause of death coded as colorectal cancer based on the International Classification of Diseases, 10th edition (ICD-10) was used (C18.0-C18.9). The study was approved by the Ethics Committee of The National Center for Chronic and Noncommunicable Disease Control and Prevention.</div></div><div><h3>Findings</h3><div>The loss of life expectancy due to colorectal cancer in China in 2020 was 0.15 years, slightly higher in men (0.154 years) than in women (0.147 years). Loss of life expectancy due to colorectal cancer is on an increasing trend between 2005 and 2020, for both genders, with a higher increase for men (0.03) than for women (0.02). The provinces with the highest loss of life expectancy due to colorectal cancer in 2020 were Beijing (0.30), Zhejiang (0.26), and Shanghai (0.26), and the lowest were Tibet (0.04), Hebei (0.09), and Henan (0.10). Among all 31 mainland provinces, 3 provinces (Hebei, Henan and Jiangxi) showed a decreasing trend for loss of life expectancy due to colorectal cancer. For the remaining provinces, Tianjin (96.97%), Fujian 80.28%), and Beijing (70.28%) had the highest increase in loss of life expectancy due to colorectal cancer during the study period.</div></div><div><h3>Interpretation</h3><div>The loss of life expectancy due to colorectal cancer is increasing during 2005-2020, indicating it remains a major public health problem in China, particularly in economically developed provinces. The strengths of this study are the use of loss of life expectancy as the indicator to measure the burden caused by colorectal cancer and its temporal trend based on nationwide data. The limitation of this study is that we were unable to analyze the associated factors for the variations between different provinces.</div></div>\",\"PeriodicalId\":22792,\"journal\":{\"name\":\"The Lancet Regional Health: Western Pacific\",\"volume\":\"55 \",\"pages\":\"Article 101338\"},\"PeriodicalIF\":8.1000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Regional Health: Western Pacific\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666606524003328\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666606524003328","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

到2020年,结直肠癌是中国癌症死亡的第四大原因,2005年至2020年,经济发达地区结直肠癌死亡率有所上升。本研究旨在探讨2005年至2020年中国和所有大陆省份因结直肠癌导致的预期寿命损失的时间趋势。方法死亡率数据来自中国国家死亡率监测系统(NMSS),该系统覆盖31个具有省级代表性的直辖市的3亿多人口。漏报率用于调整各种原因和结直肠癌的死亡率。人口统计数据来自国家统计局。我们用简略寿命表法计算预期寿命。结直肠癌导致的预期寿命损失是按性别和省份排除结直肠癌死亡后的预期寿命。根据国际疾病分类第10版(ICD-10),潜在死亡原因编码为结直肠癌(C18.0-C18.9)。这项研究得到了美国国家慢性和非传染性疾病控制与预防中心伦理委员会的批准。研究结果:到2020年,中国结直肠癌导致的预期寿命损失为0.15岁,男性(0.154岁)略高于女性(0.147岁)。2005年至2020年期间,因结直肠癌导致的预期寿命损失呈上升趋势,无论男女,其中男性的增幅(0.03)高于女性(0.02)。2020年因结直肠癌导致的预期寿命损失最高的省份是北京(0.30)、浙江(0.26)和上海(0.26),最低的是西藏(0.04)、河北(0.09)和河南(0.10)。在内地31个省份中,有3个省份(河北、河南和江西)因结直肠癌导致的预期寿命下降。其余省份中,天津(96.97%)、福建(80.28%)和北京(70.28%)在研究期间因结直肠癌导致的预期寿命损失增幅最高。2005-2020年期间,结直肠癌导致的预期寿命损失正在增加,这表明它仍然是中国的一个主要公共卫生问题,特别是在经济发达省份。本研究的优势在于使用预期寿命损失作为指标来衡量结直肠癌造成的负担及其基于全国数据的时间趋势。本研究的局限性在于我们无法分析不同省份间差异的相关因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Loss of life expectancy due to colorectal cancer at national and subnational level in China, 2005-2020: a retrospective population-based study from China national mortality surveillance system

Background

Colorectal cancer was the fourth leading cause of cancer death in China in 2020, and mortality due to colorectal cancer increased in economically developed regions between 2005 and 2020. This study aimed to explore the temporal trends in loss of life expectancy due to colorectal cancer in China and all mainland provinces from 2005 to 2020.

Methods

The mortality data were obtained from the China National Mortality Surveillance System (NMSS), which covers a population of more than 300 million people in 31 provincial-level administrations with provincial-level representativeness. Under-reporting rate was used to adjust for death rates from all cause and colorectal cancer. The demographic data were obtained from the National Bureau of Statistic. We used the abbreviated life table method to calculate life expectancy. Loss of life expectancy due to colorectal cancer was calculated as the life expectancy after excluding colorectal cancer deaths in the whole population by gender and provinces. Underlying cause of death coded as colorectal cancer based on the International Classification of Diseases, 10th edition (ICD-10) was used (C18.0-C18.9). The study was approved by the Ethics Committee of The National Center for Chronic and Noncommunicable Disease Control and Prevention.

Findings

The loss of life expectancy due to colorectal cancer in China in 2020 was 0.15 years, slightly higher in men (0.154 years) than in women (0.147 years). Loss of life expectancy due to colorectal cancer is on an increasing trend between 2005 and 2020, for both genders, with a higher increase for men (0.03) than for women (0.02). The provinces with the highest loss of life expectancy due to colorectal cancer in 2020 were Beijing (0.30), Zhejiang (0.26), and Shanghai (0.26), and the lowest were Tibet (0.04), Hebei (0.09), and Henan (0.10). Among all 31 mainland provinces, 3 provinces (Hebei, Henan and Jiangxi) showed a decreasing trend for loss of life expectancy due to colorectal cancer. For the remaining provinces, Tianjin (96.97%), Fujian 80.28%), and Beijing (70.28%) had the highest increase in loss of life expectancy due to colorectal cancer during the study period.

Interpretation

The loss of life expectancy due to colorectal cancer is increasing during 2005-2020, indicating it remains a major public health problem in China, particularly in economically developed provinces. The strengths of this study are the use of loss of life expectancy as the indicator to measure the burden caused by colorectal cancer and its temporal trend based on nationwide data. The limitation of this study is that we were unable to analyze the associated factors for the variations between different provinces.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
The Lancet Regional Health: Western Pacific
The Lancet Regional Health: Western Pacific Medicine-Pediatrics, Perinatology and Child Health
CiteScore
8.80
自引率
2.80%
发文量
305
审稿时长
11 weeks
期刊介绍: The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.
期刊最新文献
Making older women more visible in healthy ageing. Longitudinal aging research in East and Southeast Asia: representativeness or depth? Effect of a comprehensive package based on combined C-reactive protein and serum amyloid A point-of-care testing on antibiotic prescribing for acute respiratory tract infections at village clinics in China: a cluster randomised controlled trial. Stage shifts in national lung adenocarcinoma and the impact of opportunistic self-initiated LDCT screening in Taiwan: a nationwide population-based cohort study. Seroprotection to five vaccine-preventable diseases among children in East New Britain, Papua New Guinea.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1